Bioventus Agrees to Pay More Than $3.6 Million to Resolve False Claims Act Violations
GREENSBORO, N.C. - Bioventus, LLC, a global medical technology company, has agreed to pay the government $3,609,087.00 to resolve allegations that Bioventus violated the False Claims Act by submitting improperly completed certificates of medical necessity (CMN) for medically unnecessary devices from October 1, 2012 through December 31, 2018, U.S. Attorney Matthew G. T. Martin for the Middle District of North Carolina announced.
- Date:February 25, 2021
- Agency:U.S. Attorney’s Office, Middle District of North Carolina
- Criminal and Civil Actions